Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$38.60
-1.83%
Mkt Cap $1.60B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (14 analysts)
$73.67
Range $63.00 – $88.00
Implied Upside
+90.9%
Consensus $73.67 vs current $38.60